CURRENT MEDICATIONS OVERVIEW,,
MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST
"Citalopram",CYP2C19,Usual prescribing considerations apply
"Diazepam",CYP2C19,Usual prescribing considerations apply
"Quetiapine",CYP3A4,Usual prescribing considerations apply
MEDICATIONS WITH MAJOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Statins,Simvastatin,"SLCO1B1CYP3A4",Adverse effects,CPIC2
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"ADHD -miscellaneous agents",Atomoxetine,CYP2D6,Adverse effects,-
Antiarrhythmics,Flecainide,CYP2D6,Adverse effects,DPWG3
"",Propafenone,CYP2D6,Adverse effects,DPWG3
Anticoagulants,Acenocoumarol,"VKORC1CYP2C9","Increased acenocoumarolsensitivity",
"",Warfarin,"VKORC1CYP2C9",Increased warfarin sensitivity,FDA4
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Venlafaxine,CYP2D6,Adverse effects,DPWG3
"Antidepressants -SSRIs",Paroxetine,CYP2D6,Adverse effects,CPIC1
"Antidepressants -tricyclicantidepressants",Desipramine,CYP2D6,Adverse effects,CPIC5
"",Nortriptyline,CYP2D6,Adverse effects,CPIC5
Antiemetics,Ondansetron,CYP2D6,"Increased therapeutic and/oradverse effects",CPIC6
MEDICATIONS WITH MINOR PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
Antihistamines,Chlorpheniramine,CYP2D6,Adverse effects,-
"",Dexchlorpheniramine,CYP2D6,Adverse effects,-
Antipsychotics,Aripiprazole,CYP2D6,Adverse effects,-
"",Brexpiprazole,CYP2D6,Adverse effects,-
"",Haloperidol,CYP2D6,Adverse effects,-
"",Pimozide,CYP2D6,Adverse effects,
"",Risperidone,CYP2D6,Adverse effects,DPWG3
"",Zuclopenthixol,CYP2D6,Adverse effects,DPWG3
Antitussives,Dextromethorphan,CYP2D6,Altered response,-
Beta blockers,Metoprolol,CYP2D6,Adverse effects,DPWG3
"Immunomodulatorsand antineoplastics",Tamoxifen,CYP2D6,Reduced / inadequate response,CPIC7
Miscellaneous,Eliglustat,CYP2D6,Adverse effects,TGA8
Neurological drugs,Tetrabenazine,CYP2D6,Adverse effects,FDA9
Opioid Analgesics,Morphine,OPRM1,"Associated with reducedresponse to morphine",-
"Proton pumpinhibitors",Dexlansoprazole,CYP2C19,Reduced / inadequate response,-
"",Esomeprazole,CYP2C19,Reduced / inadequate response,-
"",Lansoprazole,CYP2C19,Reduced / inadequate response,-
"",Omeprazole,CYP2C19,Reduced / inadequate response,-
"",Pantoprazole,CYP2C19,Reduced / inadequate response,-
"",Rabeprazole,CYP2C19,Reduced / inadequate response,-
Statins,Atorvastatin,"SLCO1B1CYP3A4",Adverse effects,-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Angiotensin receptorblockers",Irbesartan,CYP2C9,"No altered effect predicted bygenotype",-
"",Losartan,CYP2C9,"No altered effect predicted bygenotype",-
"Anticholinergics(genitourinary)",Darifenacin,CYP2D6,"No altered effect predicted bygenotype",-
"",Fesoterodine,CYP2D6,"No altered effect predicted bygenotype",-
"",Tolterodine,CYP2D6,"No altered effect predicted bygenotype",-
Anticholinesterases,Donepezil,CYP2D6,"No altered effect predicted bygenotype",-
"",Galantamine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -other",Mirtazapine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
"",Moclobemide,CYP2C19,"No altered effect predicted bygenotype",-
"",Vortioxetine,CYP2D6,"No altered effect predicted bygenotype",-
"Antidepressants -serotoninnoradrenalinereuptake inhibitors",Duloxetine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Antidepressants -SSRIs",Citalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC1
"",Escitalopram,CYP2C19,"No altered effect predicted bygenotype",CPIC1
"",Fluoxetine,"CYP2D6CYP2C9","No altered effect predicted bygenotype",-
"",Fluvoxamine,"CYP2D6CYP1A2","No altered effect predicted bygenotype",CPIC1
"",Sertraline,CYP2C19,"No altered effect predicted bygenotype",CPIC1
"Antidepressants -tricyclicantidepressants",Amitriptyline,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC5
"",Clomipramine,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC5
"",Doxepin,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC5
"",Imipramine,"CYP2D6CYP2C19","No altered effect predicted bygenotype",CPIC5
Antidiabetics,Gliclazide,"CYP2C9CYP2C19","No altered effect predicted bygenotype",-
"",Glimepiride,CYP2C9,"No altered effect predicted bygenotype",-
"",Glyburide,CYP2C9,"No altered effect predicted bygenotype",-
Antiemetics,Metoclopramide,CYP2D6,"No altered effect predicted bygenotype",-
Antiepileptics,Phenytoin,CYP2C9,"No altered effect predicted bygenotype",CPIC10
Antifungals - Azoles,Voriconazole,CYP2C19,"No altered effect predicted bygenotype",CPIC11
Antihistamines,Promethazine,CYP2D6,Adverse effects,-
Antiplatelet drugs,Clopidogrel,CYP2C19,"No altered effect predicted bygenotype",CPIC12
Antipsychotics,Chlorpromazine,CYP2D6,"No altered effect predicted bygenotype",-
"",Clozapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Olanzapine,CYP1A2,"No altered effect predicted bygenotype",-
"",Quetiapine,CYP3A4,"No altered effect predicted bygenotype",-
Benzodiazepines,Clobazam,CYP2C19,"No altered effect predicted bygenotype",-
"",Diazepam,CYP2C19,"No altered effect predicted bygenotype",-
Beta blockers,Carvedilol,CYP2D6,"No altered effect predicted bygenotype",-
"",Nebivolol,CYP2D6,"No altered effect predicted bygenotype",-
"",Propranolol,"CYP2D6CYP1A2","No altered effect predicted bygenotype",-
Calcineurin inhibitors,Tacrolimus,CYP3A5,"No altered effect predicted bygenotype",CPIC13
MEDICATIONS WITH USUAL PRESCRIBING CONSIDERATIONS,,,,
DRUG CATEGORY,MEDICATION,"GENE(S)INVOLVED",POTENTIAL CLINICAL ISSUES,"PUBLISHEDGUIDELINES"
"Glaucoma - ocularpreparations",Timolol,CYP2D6,"No altered effect predicted bygenotype",-
Hypnotics,Melatonin,CYP1A2,"No altered effect predicted bygenotype",-
Miscellaneous,Atazanavir,CYP3A5,"No altered effect predicted bygenotype",-
"",Cyclophosphamide,CYP2C19,"No altered effect predicted bygenotype",-
"",Naltrexone,OPRM1,"No altered effect predicted bygenotype for naltrexone",
"",Proguanil,CYP2C19,"No altered effect predicted bygenotype",-
NSAIDs,Celecoxib,CYP2C9,"No altered effect predicted bygenotype",-
"",Diclofenac,CYP2C9,"No altered effect predicted bygenotype",-
"",Flurbiprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Ibuprofen,CYP2C9,"No altered effect predicted bygenotype",-
"",Indomethacin,CYP2C9,"No altered effect predicted bygenotype",-
"",Mefenamic Acid,CYP2C9,"No altered effect predicted bygenotype",-
"",Meloxicam,CYP2C9,"No altered effect predicted bygenotype",-
"",Piroxicam,CYP2C9,"No altered effect predicted bygenotype",-
Opioid Analgesics,Codeine,"CYP2D6OPRM1","Associated with reducedsensitivity to codeine",CPIC14
"",Hydrocodone,CYP2D6,"No altered effect predicted bygenotype",
"",Oxycodone,CYP2D6,"No altered effect predicted bygenotype",DPWG3
"",Tramadol,CYP2D6,"No altered effect predicted bygenotype",DPWG3
Psychostimulants,Dextroamphetamine,CYP2D6,"No altered effect predicted bygenotype",-
"",Lisdexamfetamine,CYP2D6,"No altered effect predicted bygenotype",-
Statins,Fluvastatin,"SLCO1B1CYP2C9","No altered effect predicted bygenotype",-
Pravastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
Rosuvastatin,SLCO1B1,"No altered effect predicted bygenotype",-,
